Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD

Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease

(2017) Oscar Chávez-Talavera et al.   GASTROENTEROLOGY

Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease

(2016) Valerio Nobili et al.   GASTROENTEROLOGY

Effect of HFD/STZ on expression of genes involved in lipid, cholesterol and glucose metabolism in rats

(2016) Luisa Pozzo et al.   LIFE SCIENCES

FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho

(2016) Ting Fu et al.   MOLECULAR ENDOCRINOLOGY

Bile acids as metabolic regulators

(2015) Tiangang Li et al.   CURRENT OPINION IN GASTROENTEROLOGY

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

(2015) Brent A Neuschwander-Tetri et al.   LANCET

Nonalcoholic fatty liver disease

(2015) Elizabeth M. Brunt et al.   Nature Reviews Disease Primers

Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal

(2014) Johannes Schmitt et al.   LIVER INTERNATIONAL

FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation

(2014) Jun Yao   WORLD JOURNAL OF GASTROENTEROLOGY

Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease

(2013) Anna Alisi et al.   PLoS One

Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease

(2012) Naim Alkhouri et al.   JOURNAL OF HEPATOLOGY

Diagnosis of Nonalcoholic Fatty Liver Disease in Children and Adolescents

(2012) Pietro Vajro et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Insulin-dependent suppression of cholesterol 7α-hydroxlase is a possible link between glucose and cholesterol metabolisms

(2011) Wook-Ha Park et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Epidemiology of Non-Alcoholic Fatty Liver Disease

(2010) Stefano Bellentani et al.   DIGESTIVE DISEASES

Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis

(2009) Songwen Zhang et al.   JOURNAL OF HEPATOLOGY

Is juvenile liver biopsy unsafe? Putting an end to a common misapprehension

(2009) Andrea Pietrobattista et al.   PEDIATRIC RADIOLOGY